Sambrinvest
VC Fund
Gosselies, Belgium
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Sambrinvest invests in
Stages Sambrinvest invests in
Countries Sambrinvest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $544k–$24M
- Series A
- $987k–$46M
- Series B
- $4.4M–$45M
Investment Focus
Industry
- Biotechnology 15 (38%)
- Health Care 13 (33%)
- Medical 7 (18%)
- Therapeutics 5 (13%)
- Pharmaceutical 5 (13%)
Stage
- Seed 15 (38%)
- Series A 10 (25%)
- Series B 7 (18%)
- Funding Round 5 (13%)
- Pre-Seed 1 (3%)
Country
- Belgium 24 (60%)
- France 7 (18%)
- Spain 1 (3%)
- The Netherlands 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anne Prignon
Managing Director
|
Managing Director | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Brenus Pharma
|
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance over treatment. | $12.6M / Series A / Jul 20, 2026 | |
Vertical Compute
|
Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings. | $42.9M / Seed / Mar 04, 2026 | |
Enodia Therapeutics
|
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases. | $24.2M / Seed / Jan 08, 2026 | |
Sunrise
|
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. | $29.2M / Sep 25, 2025 | |
Elkedonia
|
Elkedonia is a biotech company dedicated to transforming antidepressant therapy. It aims to develop a groundbreaking antidepressant treatment that is accessible, fast-acting, and free from the risks of dependence, sedation, or psychotic effects. | $12.9M / Seed / Jun 11, 2025 | |
ATB Therapeutics
|
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients. | $57.2M / Series A / Nov 18, 2024 | |
AdipoPharma
|
AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases. | Nov 11, 2024 | |
|
AdipoPharma
|
AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases. | $10.6M / Series A / Nov 11, 2024 | |
AbolerIS Pharma
|
AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance. | $29.2M / Series A / Sep 18, 2023 | |
cikisi
|
Specialized in Web Intelligence (collecting, searching and filtering web information). Help companies and organizations to take advantage of Web information that are relevant to their development. Develops and commercializes Cikisi WMT, a Web Intelligence Solution. | $2.9M / Seed / Sep 01, 2023 | |
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sambrinvest invest in?
Sambrinvest invests primarily in Biotechnology, Health Care and Medical startups, most often at Seed and Series A stage. Most of the 40 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sambrinvest's check size?
Sambrinvest typically joins rounds of $544k–$24M at Seed, $987k–$46M at Series A and $4.4M–$45M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sambrinvest participates in.
How do I contact Sambrinvest?
Public channels for Sambrinvest include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sambrinvest?
The team at Sambrinvest includes Anne Prignon (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
